CENTESSA PHARMACEUTICALS-ADR(NASDAQ:CNTA) stock News

CNTA Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Chartmill

CENTESSA PHARMACEUTICALS-ADR (NASDAQ:CNTA) Shows Strong Technical Setup for Potential Breakout

a day ago - By: Benzinga - Mentions: IBIO ABP AVR STTK ...

12 Health Care Stocks Moving In Monday's After-Market Session

a month ago - By: Benzinga - Mentions: DNTH KRRO

3 Biotech Stocks Showing Strength With Big Spikes In Momentum Scores

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

3 months ago - By: Investor's Business Daily - Mentions: RY RY.CA ALKS TAK ...

Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.

4 months ago - By: Yahoo Finance - Mentions: AGEN HON ITGR TTEK ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

4 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

4 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

6 months ago - By: Yahoo Finance - Mentions: GEHC IDYA BCYC EWTX ...

Here's Why GE HealthCare Stock Sank in April

6 months ago - By: Yahoo Finance - Mentions: XYLD JEPQ MTB

High-yield savings rates today: May 5, 2025 | APYs remain elevated despite a slight decline

6 months ago - By: Yahoo Finance - Mentions: DHI CMG

Is Centessa Pharmaceuticals plc (CNTA) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

7 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

7 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

8 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

8 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

9 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

10 months ago - By: Centessa Pharmaceuticals plc